BR9709528A - Compostos antivirais - Google Patents

Compostos antivirais

Info

Publication number: BR9709528A
Authority: BR; Brazil
Prior art keywords: antiviral compounds; antiviral; compounds
Prior art date: 1996-06-05

Application number

BR9709528A

Other languages

English (en)

Inventor

Louis Nickolaus Jungheim

Timothy Alan Shepherd

Wayne Alfred Spitzer

Mark Joseph Tebbe

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-05

Filing date

1997-06-05

Publication date

1999-08-10

1997-06-05 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-08-10 Publication of BR9709528A publication Critical patent/BR9709528A/pt

Links

230000000840 anti-viral effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BR9709528A 1996-06-05 1997-06-05 Compostos antivirais BR9709528A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1917096P	1996-06-05	1996-06-05
PCT/US1997/008848 WO1997046237A1 (en)	1996-06-05	1997-06-05	Anti-viral compounds

Publications (1)

Publication Number	Publication Date
BR9709528A true BR9709528A (pt)	1999-08-10

Family

ID=21791797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9709528A BR9709528A (pt)	1996-06-05	1997-06-05	Compostos antivirais

Country Status (9)

Country	Link
EP (1)	EP0906097A4 (pt)
JP (1)	JP2000511899A (pt)
KR (1)	KR20000016346A (pt)
CN (1)	CN1220601A (pt)
AU (1)	AU3212897A (pt)
BR (1)	BR9709528A (pt)
CA (1)	CA2257296A1 (pt)
EA (1)	EA001316B1 (pt)
WO (1)	WO1997046237A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5821242A (en) *	1996-06-06	1998-10-13	Eli Lilly And Company	Anti-viral compounds
AU6031898A (en) *	1997-01-22	1998-08-07	Eli Lilly And Company	Anti-viral compounds
AU7715198A (en) *	1997-06-04	1998-12-21	Eli Lilly And Company	Anti-viral compounds
KR20010025055A (ko) *	1998-05-20	2001-03-26	피터 지. 스트링거	항바이러스 화합물
EP1162196A4 (en) *	1999-12-27	2003-04-16	Japan Tobacco Inc	COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
US6770666B2 (en)	1999-12-27	2004-08-03	Japan Tobacco Inc.	Fused-ring compounds and use thereof as drugs
CA2534649A1 (en)	2003-08-01	2005-02-10	Genelabs Technologies, Inc.	Bicyclic imidazol derivatives against flaviviridae
US20070049593A1 (en)	2004-02-24	2007-03-01	Japan Tobacco Inc.	Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
PT1719773E (pt)	2004-02-24	2009-06-03	Japan Tobacco Inc	Compostos heterotetracíclicos fundidos e a sua utilização como inibidores da polimerase do hcv
US7659263B2 (en)	2004-11-12	2010-02-09	Japan Tobacco Inc.	Thienopyrrole compound and use thereof as HCV polymerase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4420479A (en) *	1982-04-08	1983-12-13	Eli Lilly And Company	Olefinic benzimidazoles, formulations, and antiviral methods
US4434288A (en) *	1982-04-08	1984-02-28	Eli Lilly And Company	Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4492708A (en) *	1982-09-27	1985-01-08	Eli Lilly And Company	Antiviral benzimidazoles

1997
- 1997-06-05 JP JP10500630A patent/JP2000511899A/ja active Pending
- 1997-06-05 WO PCT/US1997/008848 patent/WO1997046237A1/en not_active Ceased
- 1997-06-05 BR BR9709528A patent/BR9709528A/pt not_active Application Discontinuation
- 1997-06-05 EA EA199801078A patent/EA001316B1/ru not_active IP Right Cessation
- 1997-06-05 AU AU32128/97A patent/AU3212897A/en not_active Abandoned
- 1997-06-05 KR KR1019980709919A patent/KR20000016346A/ko not_active Withdrawn
- 1997-06-05 CA CA002257296A patent/CA2257296A1/en not_active Abandoned
- 1997-06-05 EP EP97927738A patent/EP0906097A4/en not_active Withdrawn
- 1997-06-05 CN CN97195098A patent/CN1220601A/zh active Pending

Also Published As

Publication number	Publication date
EP0906097A1 (en)	1999-04-07
WO1997046237A1 (en)	1997-12-11
EA199801078A1 (ru)	1999-04-29
CN1220601A (zh)	1999-06-23
AU3212897A (en)	1998-01-05
EP0906097A4 (en)	2000-12-13
JP2000511899A (ja)	2000-09-12
KR20000016346A (ko)	2000-03-25
CA2257296A1 (en)	1997-12-11
EA001316B1 (ru)	2001-02-26

Legal Events

Date	Code	Title	Description
2004-09-28	B07A	Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
2005-03-08	B09B	Patent application refused [chapter 9.2 patent gazette]

Publication	Publication Date	Title
BR9709643A (pt)	1999-08-10	Compostos antivirais
ID19609A (id)	1998-07-23	Senyawa-senyawa heterosiklik
ID19403A (id)	1998-07-09	Senyawa-senyawa heterosiklik
ID16152A (id)	1997-09-04	Senyawa-senyawa triaril
ID15904A (id)	1997-08-14	Senyawa-senyawa tiofenopirimidina
PT860428E (pt)	2005-04-29	Compostos pirimidiona
IS5479A (is)	2000-05-03	Efnasambönd
IS5478A (is)	2000-05-03	Efnasambönd
IS5477A (is)	2000-05-03	Efnasambönd
ID22850A (id)	1999-12-09	Senyawa-senyawa pirazina
NO994877D0 (no)	1999-10-07	Kalsilytiske forbindelser
ID19476A (id)	1998-07-16	Senyawa piridilpirol
ID18685A (id)	1998-04-30	Senyawa trisiklik tersubstitusi
ID20323A (id)	1998-11-26	Senyawa-senyawa triazinilaminostilbena
DE69716924D1 (de)	2002-12-12	Phosphonat-nukleotid-verbindungen
IS5208A (is)	1999-10-05	Efnasambönd
NO20005795D0 (no)	2000-11-16	Antivirale forbindelser
BR9705635A (pt)	1999-05-18	Compostos
ID19490A (id)	1998-07-16	Kombinasi-kombinasi antiviral
BR9709432A (pt)	1999-08-10	Composto antivirais
DK0923594T3 (da)	2003-02-10	Bromotiacumicinforbindelser
FI970151A7 (fi)	1997-01-14	Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
IS5237A (is)	1999-11-01	Efnasambönd
DE69709659D1 (de)	2002-02-21	Halopropargyl-einschlussverbindungen
NO996544D0 (no)	1999-12-29	Forbindelser